Arthur, Jon, Chlebek, Sylvia, Yates, Sydni, Jestes, Kelli, Newby, Jordan, Lowery, Jonathan, and Totten, Madeline

Osteoporosis is a disease characterized by low bone mineral density due to the rate of bone resorption exceeding that of bone formation. Evidence indicates the Bone Morphogenetic Protein (BMP) pathway promotes bone formation...

poster

Chlebek, Sylvia, Arthur, Jon, Newby, Jordan, and Lowery, Jonathan

Osteoporosis is a disease characterized by low bone mineral density due to the rate of bone resorption exceeding that of bone formation. Substantial evidence indicates the Bone Morphogenetic Protein (BMP) pathway promotes bone...

poster

Gorrell, Ruthann, Hudnall, Aaron, Schoerning, Laura, Lawless, Warren, Newby, Jordan, Lowery, Jonathan, and Hum, Julia

Osteoporosis, a disease of low bone mineral density, affects 10 million Americans and triggers significant health problems and considerable socioeconomic burdens. Current treatments for osteoporosis have significant...

poster

Gorrell, Ruthann, Yates, Sydni, Hudnall, Aaron, Hum, Julia, Geyman, Logan, Lawless, Warren, Totten, Madeline, Newby, Jordan, Lowery, Jonathan, and Schoerning, Laura

The Bone Morphogenetic Protein (BMP) signaling pathway comprises the largest subdivision of the Transforming Growth Factor (TGFβ) superfamily. BMP signaling plays essential roles in both embryonic development and postnatal...

poster

Rosen, Vickie, Hudnall, Aaron, Eaton, Michael, Newby, Jordan, and Lowery, Jonathan

Osteoporosis is a disease of low bone mineral density (BMD) that affects 10 million Americans with an additional 34 million at risk for developing the disease. Current FDA-approved therapies for osteoporosis involve...

poster

Eaton, Michael and Newby, Jordan

Background: The Taste receptor, type 1 (TAS1R) family of heterotrimeric G protein-coupled receptors participates in monitoring energy and nutrient needs. TAS1R member 3 (TAS1R3) either recognizes amino acids such as glycine and...

poster